MiMedx Group, Inc (MDXG) Dividend History

Company News

• MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

  MediWound has initiated a global Phase III trial to evaluate the efficacy and safety of its wound debridement therapy EscharEx for the treatment of venous leg ulcers. The trial aims to assess EscharEx's ability to effectively debride chronic wounds and prepare the wound bed for healing.

  GlobeNewswire Inc.

  Featured Companies: MDWD SOLV
• Chronic Wound Care Market to Expand at a Modest 4.17% CAGR through 2031 | SkyQuest Technology

  The chronic wound care market is expected to grow at a CAGR of 4.17% from 2024 to 2031, driven by the high prevalence of chronic diseases and advancements in wound care technologies. The market is segmented by product, application, end-user, and region, with North America leading due to its developed healthcare infrastructure.

  Benzinga

  Featured Companies: BAX CAH IART JNJ MMM
• MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

  The article highlights the benefits of placental allografts for wound care and surgical procedures, featuring two individuals who had successful recoveries using MIMEDX's products. The article is expected to increase awareness about the unique properties and growing clinical use of placental-derived products.

  GlobeNewswire Inc.
• MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall

  MIMEDX, a leader in wound care products, is showcasing its latest research and clinical evidence at the Symposium on Advanced Wound Care (SAWC) Fall meeting. The company is sponsoring a lunch symposium and a hands-on skills lab, and has seven accepted posters on various topics related to wound healing.

  GlobeNewswire Inc.
• MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

  MARIETTA, Ga., June 26, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the appointment of Kim Moller to Chief Commercial Officer. Ms. Moller has been serving as the Company’s Senior Vice President, Sales since August 2020.

  GlobeNewswire Inc.